BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 38331927)

  • 1. The interaction between DNA methylation and tumor immune microenvironment: from the laboratory to clinical applications.
    Zhu D; Zeng S; Su C; Li J; Xuan Y; Lin Y; Xu E; Fan Q
    Clin Epigenetics; 2024 Feb; 16(1):24. PubMed ID: 38331927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets.
    Yang J; Xu J; Wang W; Zhang B; Yu X; Shi S
    Signal Transduct Target Ther; 2023 May; 8(1):210. PubMed ID: 37217462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic remodeling of the immune landscape in cancer: therapeutic hurdles and opportunities.
    Tien FM; Lu HH; Lin SY; Tsai HC
    J Biomed Sci; 2023 Jan; 30(1):3. PubMed ID: 36627707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Cancer Epigenome: Exploiting Its Vulnerabilities for Immunotherapy.
    Loo Yau H; Ettayebi I; De Carvalho DD
    Trends Cell Biol; 2019 Jan; 29(1):31-43. PubMed ID: 30153961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Epigenetic-Based Nanotechnology for Cancer Therapy: Modulating the Tumor Microenvironment.
    Zhang J; Huang L; Ge G; Hu K
    Adv Sci (Weinh); 2023 Mar; 10(7):e2206169. PubMed ID: 36599655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic modulation of antitumor immunity for improved cancer immunotherapy.
    Dai E; Zhu Z; Wahed S; Qu Z; Storkus WJ; Guo ZS
    Mol Cancer; 2021 Dec; 20(1):171. PubMed ID: 34930302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. m
    Zhang B; Wu Q; Li B; Wang D; Wang L; Zhou YL
    Mol Cancer; 2020 Mar; 19(1):53. PubMed ID: 32164750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reshaping the tumour immune microenvironment in solid tumours via tumour cell and immune cell DNA methylation: from mechanisms to therapeutics.
    Zhong F; Lin Y; Zhao L; Yang C; Ye Y; Shen Z
    Br J Cancer; 2023 Jul; 129(1):24-37. PubMed ID: 37117649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation of immune synapse genes modulates tumor immunogenicity.
    Berglund A; Mills M; Putney RM; Hamaidi I; Mulé J; Kim S
    J Clin Invest; 2020 Feb; 130(2):974-980. PubMed ID: 31714899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation in the tumor microenvironment.
    Zhang MW; Fujiwara K; Che X; Zheng S; Zheng L
    J Zhejiang Univ Sci B; 2017 May; 18(5):365-372. PubMed ID: 28471108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic Modifiers: Anti-Neoplastic Drugs With Immunomodulating Potential.
    Maes K; Mondino A; Lasarte JJ; Agirre X; Vanderkerken K; Prosper F; Breckpot K
    Front Immunol; 2021; 12():652160. PubMed ID: 33859645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetics in modulating immune functions of stromal and immune cells in the tumor microenvironment.
    Pan X; Zheng L
    Cell Mol Immunol; 2020 Sep; 17(9):940-953. PubMed ID: 32699350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic modulation of antitumor immunity and immunotherapy response in breast cancer: biological mechanisms and clinical implications.
    Yin J; Gu T; Chaudhry N; Davidson NE; Huang Y
    Front Immunol; 2023; 14():1325615. PubMed ID: 38268926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer Epigenetics, Tumor Immunity, and Immunotherapy.
    Cao J; Yan Q
    Trends Cancer; 2020 Jul; 6(7):580-592. PubMed ID: 32610068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation regulator-mediated modification patterns and tumor microenvironment characterization in glioma.
    Luo H; Ye M; Hu Y; Wu M; Cheng M; Zhu X; Huang K
    Aging (Albany NY); 2022 Sep; 14(19):7824-7850. PubMed ID: 36152044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetics Regulates Antitumor Immunity in Melanoma.
    Chen Y; Yi X; Sun N; Guo W; Li C
    Front Immunol; 2022; 13():868786. PubMed ID: 35693795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Mechanisms of Resistance to Immune Checkpoint Inhibitors.
    Perrier A; Didelot A; Laurent-Puig P; Blons H; Garinet S
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32708698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic regulation of immune checkpoints: another target for cancer immunotherapy?
    Ali MA; Matboli M; Tarek M; Reda M; Kamal KM; Nouh M; Ashry AM; El-Bab AF; Mesalam HA; Shafei AE; Abdel-Rahman O
    Immunotherapy; 2017 Jan; 9(1):99-108. PubMed ID: 28000527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic Regulation of Cancer Immune Cells.
    Avella Patino DM; Radhakrishnan V; Suvilesh KN; Manjunath Y; Li G; Kimchi ET; Staveley-O'Carroll KF; Warren WC; Kaifi JT; Mitchem JB
    Semin Cancer Biol; 2022 Aug; 83():377-383. PubMed ID: 34182142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic interplay between immune, stromal and cancer cells in the tumor microenvironment.
    Garcia-Gomez A; RodrĂ­guez-Ubreva J; Ballestar E
    Clin Immunol; 2018 Nov; 196():64-71. PubMed ID: 29501540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.